VAPR partners with investigators and scientists from across the country to design and develop critical reagents for basic research, translational research, and large-molecule therapeutics. Our central focus is the design, development, and production of high quality monoclonal antibodies, polyclonal antibodies, and recombinant proteins, as well as, providing an extensive array of related services.

Our broad experience and deep expertise allows us to pursue the most challenging protein and antibody projects.